Seagate Technology Holdings PLC vs TransMedics Group Inc — how do they compare? Seagate Technology Holdings PLC trades at $783 (market cap $176.19B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Seagate Technology Holdings PLC is far larger — about 64.3× TransMedics Group Inc's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Seagate Technology Holdings PLC for 41 Days and TransMedics Group Inc for 24 Days on average.
| STX | TMDX | |
|---|---|---|
Market Cap | $176.19B | $2.74B |
Volume | 5,061,875 | 949,331 |
Sector | Technology | Health |
52-Week High | $1.09K | $150.42 |
52-Week Low | $211.63 | $61.99 |
Typical Hold Time | 41 Days | 24 Days |
Enterprise Value | $178.34B | $3.13B |
Dividend Yield | 0.38% | — |
Signals from Pluang's Aura AI — not financial advice
Seagate Technology (STX) trades at $774.83, down 4.03% amid concerns about increased competition from Toshiba's planned hard drive production expansion. The stock shows strong fundamental performance with Q2 2026 EPS of $5.71 beating expectations by 12%, and robust profitability metrics including 26.11% net income margin and 371.53% ROE. Technical indicators signal bearish momentum with price below key pivot points, though RSI suggests potential oversold conditions. Analyst consensus remains positive with 54% buy ratings and $1,130 price target representing 46% upside potential.
STX presents a compelling growth story driven by AI storage demand, but faces near-term headwinds from competitive threats. The company's strong earnings beat streak and projected 2026 revenue growth to $12.2B support long-term optimism, while current valuation multiples appear elevated. Key risks include pricing pressure from new capacity and dependency on AI infrastructure spending cycles.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →